Modified Latency Associated Protein Construct

The present invention provides a fusion protein comprising a latency associated peptide (LAP), a pharmaceutically active agent and an amino acid sequence comprising a dimerisation domain, wherein the LAP and the pharmaceutically active agent are connected by an amino acid sequence comprising a prole...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Muhammad, Hawzheen, Gould, David James, Chernajovsky, Yuti, Adams, Gillian, Mullen, Lisa
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Muhammad, Hawzheen
Gould, David James
Chernajovsky, Yuti
Adams, Gillian
Mullen, Lisa
description The present invention provides a fusion protein comprising a latency associated peptide (LAP), a pharmaceutically active agent and an amino acid sequence comprising a dimerisation domain, wherein the LAP and the pharmaceutically active agent are connected by an amino acid sequence comprising a proleolytic cleavage site. Also provided are nucleic acids enclosing such fusion proteins, process for their preparation, pharmaceutical compositions, kits and uses thereof in medicine.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2020062814A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2020062814A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2020062814A13</originalsourceid><addsrcrecordid>eNrjZND1zU_JTMtMTVHwSSxJzUuuVHAsLs5PzgRyUhQCivJLUjPzFJzz84pLikqTS3gYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXxosJGBkYGBmZGFoYmjoTFxqgBqZCsR</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Modified Latency Associated Protein Construct</title><source>esp@cenet</source><creator>Muhammad, Hawzheen ; Gould, David James ; Chernajovsky, Yuti ; Adams, Gillian ; Mullen, Lisa</creator><creatorcontrib>Muhammad, Hawzheen ; Gould, David James ; Chernajovsky, Yuti ; Adams, Gillian ; Mullen, Lisa</creatorcontrib><description>The present invention provides a fusion protein comprising a latency associated peptide (LAP), a pharmaceutically active agent and an amino acid sequence comprising a dimerisation domain, wherein the LAP and the pharmaceutically active agent are connected by an amino acid sequence comprising a proleolytic cleavage site. Also provided are nucleic acids enclosing such fusion proteins, process for their preparation, pharmaceutical compositions, kits and uses thereof in medicine.</description><language>eng</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200227&amp;DB=EPODOC&amp;CC=US&amp;NR=2020062814A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25565,76548</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200227&amp;DB=EPODOC&amp;CC=US&amp;NR=2020062814A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Muhammad, Hawzheen</creatorcontrib><creatorcontrib>Gould, David James</creatorcontrib><creatorcontrib>Chernajovsky, Yuti</creatorcontrib><creatorcontrib>Adams, Gillian</creatorcontrib><creatorcontrib>Mullen, Lisa</creatorcontrib><title>Modified Latency Associated Protein Construct</title><description>The present invention provides a fusion protein comprising a latency associated peptide (LAP), a pharmaceutically active agent and an amino acid sequence comprising a dimerisation domain, wherein the LAP and the pharmaceutically active agent are connected by an amino acid sequence comprising a proleolytic cleavage site. Also provided are nucleic acids enclosing such fusion proteins, process for their preparation, pharmaceutical compositions, kits and uses thereof in medicine.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZND1zU_JTMtMTVHwSSxJzUuuVHAsLs5PzgRyUhQCivJLUjPzFJzz84pLikqTS3gYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXxosJGBkYGBmZGFoYmjoTFxqgBqZCsR</recordid><startdate>20200227</startdate><enddate>20200227</enddate><creator>Muhammad, Hawzheen</creator><creator>Gould, David James</creator><creator>Chernajovsky, Yuti</creator><creator>Adams, Gillian</creator><creator>Mullen, Lisa</creator><scope>EVB</scope></search><sort><creationdate>20200227</creationdate><title>Modified Latency Associated Protein Construct</title><author>Muhammad, Hawzheen ; Gould, David James ; Chernajovsky, Yuti ; Adams, Gillian ; Mullen, Lisa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2020062814A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2020</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>Muhammad, Hawzheen</creatorcontrib><creatorcontrib>Gould, David James</creatorcontrib><creatorcontrib>Chernajovsky, Yuti</creatorcontrib><creatorcontrib>Adams, Gillian</creatorcontrib><creatorcontrib>Mullen, Lisa</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Muhammad, Hawzheen</au><au>Gould, David James</au><au>Chernajovsky, Yuti</au><au>Adams, Gillian</au><au>Mullen, Lisa</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Modified Latency Associated Protein Construct</title><date>2020-02-27</date><risdate>2020</risdate><abstract>The present invention provides a fusion protein comprising a latency associated peptide (LAP), a pharmaceutically active agent and an amino acid sequence comprising a dimerisation domain, wherein the LAP and the pharmaceutically active agent are connected by an amino acid sequence comprising a proleolytic cleavage site. Also provided are nucleic acids enclosing such fusion proteins, process for their preparation, pharmaceutical compositions, kits and uses thereof in medicine.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2020062814A1
source esp@cenet
subjects CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
title Modified Latency Associated Protein Construct
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T14%3A50%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Muhammad,%20Hawzheen&rft.date=2020-02-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2020062814A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true